HomePersonal FinanceBanks & FinanceSpyre (SYRE) CEO On IBD Market Growth

Spyre (SYRE) CEO On IBD Market Growth

Spyre (SYRE) is a biotech company that aims to create the next-generation of inflammatory bowel disease products. CEO Cameron Tuttle joins Oliver Renick to discuss the company as it began trading on the NASDAQ following an acquisition of Aeglea. Tuttle talks about how the IBD market is expected to grow to $29B by 2028, as the CDC estimates that 3.1M Americans have been diagnosed with IBD. Tune in to find out more about the stock market today.

Morning Trade Live

06 Dec 2023

SHARE

ON AIR
1:30 am
Gamma On
replay
12:00 am
Gamma On
REPLAY
12:30 am
Gamma On
REPLAY
1:00 am
Gamma On
REPLAY
ON AIR
1:30 am
Gamma On
REPLAY
2:30 am
Gamma On
REPLAY
3:00 am
Gamma On
REPLAY
3:30 am
Gamma On
REPLAY
4:00 am
Gamma On
REPLAY
5:00 am
Gamma On
REPLAY
6:00 am
Gamma On
REPLAY
education
7:00 am
Inside the Mind of a Trader
REPLAY
education
7:30 am
Inside the Mind of a Trader
REPLAY
education
8:00 am
Inside the Mind of a Trader
REPLAY
8:30 am
Market Overtime
REPLAY
education
9:00 am
Your First Trade
REPLAY
education
9:30 am
Your First Trade
REPLAY
education
10:00 am
Your First Trade
REPLAY
education
10:30 am
Your First Trade
REPLAY
education
11:00 am
Your First Trade
REPLAY
11:30 am
Market Overtime
REPLAY
12:00 pm
Gamma On
REPLAY
12:30 pm
Gamma On
REPLAY
1:00 pm
Gamma On
REPLAY
1:30 pm
Gamma On
REPLAY
2:30 pm
Gamma On
REPLAY
3:00 pm
Gamma On
REPLAY
3:30 pm
Gamma On
REPLAY
4:00 pm
Gamma On
REPLAY
5:00 pm
Gamma On
REPLAY
6:00 pm
Gamma On
REPLAY
7:00 pm
Market Overtime
REPLAY
7:30 pm
Market Overtime
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market Overtime
REPLAY
9:00 pm
Trading 360
REPLAY
10:00 pm
Fast Market
REPLAY
11:00 pm
Next Gen Investing
REPLAY

Schwab Network's Newsletters

Daily insights for every investor